| 05 Feb, 01:21 pm | — | … | Caplin Point Laboratories Ltd - 524742 - Financial Results For The Quarter Ended December 31, 2025 | bse |
| 05 Feb, 01:14 pm | — | … | Caplin Point Laboratories Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025. | nse |
| 05 Feb, 01:08 pm | — | … | Caplin Point Laboratories Ltd - 524742 - Board Meeting Outcome for Outcome Of Board Meeting | bse |
| 03 Feb, 03:24 pm | — | … | Caplin Point Laboratories Limited has informed the Exchange regarding Change in Director(s) of the company. | nse |
| 03 Feb, 03:23 pm | — | … | Caplin Point Laboratories Ltd - 524742 - Announcement under Regulation 30 (LODR)-Change in Management | bse |
| 27 Jan, 04:03 pm | — | … | The Company has informed the Exchange regarding receipt of final approval by our Subsidiary, Caplin Steriles Limited, from the USFDA for the ANDA Methylprednisolone Acetate Injectable Suspension USP. | nse |
| 27 Jan, 03:28 pm | — | … | Caplin Point Laboratories Ltd - 524742 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 27 Jan, 11:37 am | — | … | Caplin Point Laboratories Ltd - 524742 - Board Meeting Intimation for Considering And Approving The Unaudited Financial Results For The Quarter And Nine Months Ended December 31, 2025. | bse |
| 01 Jan, 11:34 am | — | … | Caplin Point Laboratories Limited has informed the Exchange regarding 'Intimation of Press Release on Acquisition of ANDAs'. | nse |
| 12 Dec, 05:39 pm | — | … | Caplin Point Laboratories Limited has informed the Exchange regarding the successful completion of INVIMA - Colombia inspection of the injectables facility at Puducherry. | nse |
| 09 Dec, 01:47 pm | — | … | Caplin Point Laboratories Limited has informed the Exchange regarding 'Press Release' on its Subsidiary, Caplin Steriles Limited, receiving USFDA approval for its Abbreviated New Drug Application (ANDA) Linezolid Injection 600mg/300mL (2mg/mL) Single-dose Infusion Bags | nse |
| 08 Dec, 03:36 pm | — | … | Caplin Point Laboratories Ltd - 524742 - Intimation Of Press Release | bse |
| 08 Dec, 03:25 pm | — | … | Caplin Point Laboratories Limited has informed the Exchange regarding receipt of USFDA approval by its Subsidiary Caplin Steriles Limited for Acetaminophen Injection, 1000 mg/100 mL (10 mg/mL) Single-dose Infusion Bags. | nse |
| 14 Nov, 05:23 pm | — | … | Caplin Point Laboratories Limited has informed the Exchange about Acquisition of land by Subsidiary | nse |
| 12 Nov, 06:52 pm | — | … | Caplin Point Laboratories Limited has informed the Exchange about Transcript | nse |
| 12 Nov, 06:49 pm | — | … | Caplin Point Laboratories Ltd - 524742 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript | bse |
| 06 Nov, 06:36 pm | — | … | Caplin Point Laboratories Limited has informed the Exchange about Link of Recording | nse |
| 06 Nov, 06:29 pm | — | … | Caplin Point Laboratories Ltd - 524742 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | bse |
| 05 Nov, 04:37 pm | — | … | Caplin Point Laboratories Limited has informed the Exchange regarding Appointment of Mr Mr. Ashok Partheeban, Vivek Partheeban & K C John as Directors of the company w.e.f. November 05, 2025. | nse |
| 05 Nov, 04:33 pm | — | … | Caplin Point Laboratories Limited has informed the Exchange regarding Resignation of Mr Vivek Partheeban as Chief Operating Officer of the company w.e.f. November 05, 2025. | nse |
| 05 Nov, 04:26 pm | — | … | Caplin Point Laboratories Ltd - 524742 - Announcement under Regulation 30 (LODR)-Change in Management | bse |
| 05 Nov, 04:23 pm | — | … | Caplin Point Laboratories Ltd - 524742 - Announcement under Regulation 30 (LODR)-Change in Management | bse |
| 05 Nov, 01:49 pm | — | … | Caplin Point Laboratories Ltd - 524742 - Un-Audited Standalone And Consolidated Financial Results For The Quarter And Half Year Ended 30Th September 2025 | bse |
| 05 Nov, 01:45 pm | — | … | Caplin Point Laboratories Limited has submitted to the Exchange, the financial results for the period ended September 30, 2025. | nse |
| 05 Nov, 01:41 pm | — | … | Caplin Point Laboratories Ltd - 524742 - Board Meeting Outcome for Outcome Of The Board Meeting | bse |
| 29 Oct, 07:12 pm | — | … | Caplin Point Laboratories Ltd - 524742 - Board Meeting Intimation for Considering And Approving The Unaudited Financial Results Of The Company For The Quarter And Half-Year Ended September 30, 2025 | bse |
| 29 Oct, 06:33 pm | — | … | Caplin Point Laboratories Ltd - 524742 - Board Meeting Intimation for Considering And Approving, Inter-Alia, The Unaudited Financial Results Of The Company For The Quarter And Half-Year Ended September 30, 2025 | bse |
| 23 Oct, 02:51 pm | — | … | Caplin Point Laboratories Limited has informed the Exchange regarding a press release dated October 23, 2025, titled "CAPLIN STERILES GETS USFDA APPROVAL FOR NICARDIPINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE INJECTION, INFUSION BAGS". | nse |
| 23 Oct, 02:49 pm | — | … | Caplin Point Laboratories Ltd - 524742 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 29 Sept, 03:08 pm | — | … | Caplin Point Laboratories Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. | nse |
| 22 Sept, 05:10 pm | — | … | Caplin Point Laboratories Limited has informed the Exchange about change in Management | nse |
| 22 Sept, 05:04 pm | — | … | Caplin Point Laboratories Ltd - 524742 - Announcement under Regulation 30 (LODR)-Change in Management | bse |
| 03 Sept, 02:01 pm | — | … | Caplin Point Laboratories Limited has informed the Exchange regarding a press release dated September 03, 2025, titled "Press Release - Receipt of USFDA approval". | nse |
| 03 Sept, 01:58 pm | — | … | Caplin Point Laboratories Ltd - 524742 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |